Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Merck
AstraZeneca
Boehringer Ingelheim
Express Scripts

Last Updated: August 11, 2022

ZILRETTA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Zilretta, and when can generic versions of Zilretta launch?

Zilretta is a drug marketed by Pacira Pharms Inc and is included in one NDA. There are two patents protecting this drug.

This drug has fifty-one patent family members in twenty-two countries.

The generic ingredient in ZILRETTA is triamcinolone acetonide. There are fifty-one drug master file entries for this compound. Sixty-six suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for ZILRETTA
Drug patent expirations by year for ZILRETTA
Drug Prices for ZILRETTA

See drug prices for ZILRETTA

US Patents and Regulatory Information for ZILRETTA

ZILRETTA is protected by two US patents.

Patents protecting ZILRETTA

Corticosteroids for the treatment of joint pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing

Corticosteroids for the treatment of joint pain
Patent Number: See Plans and Pricing
Patent Expiration: See Plans and Pricing
Patented Use: METHOD OF TREATING PAIN OR INFLAMMATION WITH AN INJECTABLE CONTROLLED OR SUSTAINED RELEASE FORMULATION OF TRIAMCINOLONE ACETONIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pacira Pharms Inc ZILRETTA triamcinolone acetonide FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR 208845-001 Oct 6, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Pacira Pharms Inc ZILRETTA triamcinolone acetonide FOR SUSPENSION, EXTENDED RELEASE;INTRA-ARTICULAR 208845-001 Oct 6, 2017 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for ZILRETTA

See the table below for patents covering ZILRETTA around the world.

Country Patent Number Title Estimated Expiration
Singapore 187665 CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN See Plans and Pricing
European Patent Office 3701941 ORTICOSTÉROÏDES POUR LE TRAITEMENT DE LA DOULEUR ARTICULAIRE (CORTICOSTEROIDS FOR THE TREATMENT OF JOINT PAIN) See Plans and Pricing
Taiwan 201703762 Corticosteroids for the treatment of joint pain See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Medtronic
Merck
Harvard Business School
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.